Loading...
XSHE300677
Market cap2.15bUSD
Jan 16, Last price  
24.54CNY
1D
0.04%
1Q
-6.08%
IPO
51.95%
Name

Intco Medical Technology Co Ltd

Chart & Performance

D1W1MN
XSHE:300677 chart
P/E
41.12
P/S
2.28
EPS
0.60
Div Yield, %
1.17%
Shrs. gr., 5y
4.64%
Rev. gr., 5y
29.60%
Revenues
6.92b
+4.61%
713,278,630884,713,157998,021,8631,183,106,7781,750,477,6271,892,540,3052,082,935,40513,836,714,54816,240,093,6766,613,814,0566,918,724,492
Net income
383m
-39.12%
10,697,15931,854,28564,219,97286,262,517145,084,146179,338,691178,316,1927,007,048,1947,430,075,719629,070,097382,997,569
CFO
502m
-52.85%
74,522,70077,277,19376,291,01878,461,245247,484,532185,778,014329,690,3208,590,492,2468,680,078,2551,065,469,515502,407,486
Dividend
May 31, 20240.08 CNY/sh
Earnings
May 16, 2025

Profile

Intco Medical Technology Co., Ltd. engages in the research and development, production, and sale of medical disposable products and durable medical equipment in China and internationally. The company offers gloves; face masks and shields; ECG electrode; apparels, such as isolation gowns; hand sanitizer gel and spray; grounding pads; electrosurgical pencil; ESU cable and tip cleaner; and tens electrode. It also provides wheelchairs, scooters, and other medical equipment; hot and cold products, emergency treatment products, and mother and baby products; and home care products. The company was formerly known as Intco Medical Technology Co., Ltd. and changed its name to Intco Medical Technology Co., Ltd. in January 2020. Intco Medical Technology Co., Ltd. was founded in 2009 and is based in Zibo, China.
URL
https://www.intcomedical.com.cn/
IPO date
Jul 21, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
6,918,724
4.61%
6,613,814
-59.27%
Cost of revenue
6,537,724
6,345,970
Unusual Expense (Income)
NOPBT
381,000
267,844
NOPBT Margin
5.51%
4.05%
Operating Taxes
54,753
65,071
Tax Rate
14.37%
24.29%
NOPAT
326,247
202,773
Net income
382,998
-39.12%
629,070
-91.53%
Dividends
(184,919)
(412,195)
Dividend yield
1.20%
2.96%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
7,033,834
1,527,055
Long-term debt
79,191
55,158
Deferred revenue
123,985
128,526
Other long-term liabilities
Net debt
(6,315,541)
(4,335,856)
Cash flow
Cash from operating activities
502,407
1,065,470
CAPEX
(1,438,685)
(1,715,229)
Cash from investing activities
(3,976,225)
(1,866,625)
Cash from financing activities
3,009,343
549,047
FCF
1,072,793
(1,906,640)
Balance
Cash
13,181,393
6,657,101
Long term investments
247,172
(739,032)
Excess cash
13,082,630
5,587,378
Stockholders' equity
15,096,434
14,774,232
Invested Capital
10,447,019
12,122,283
ROIC
2.89%
1.69%
ROCE
1.49%
1.35%
EV
Common stock shares outstanding
660,341
662,179
Price
23.36
11.08%
21.03
-63.64%
Market cap
15,425,557
10.77%
13,925,626
-64.36%
EV
9,432,637
9,832,696
EBITDA
1,104,504
897,787
EV/EBITDA
8.54
10.95
Interest
223
28,460
Interest/NOPBT
0.06%
10.63%